4. Derma Sciences names ex-BioD CEO Olsen as wound care president
Derma Sciences (NSDQ:DSCI), which earlier this month closed the $80 million acquisition of regenerative allograft maker BioD, said it named former BioD president & CEO Russell Olsen president of its advanced wound care business. Read more